IRG1 restrains M2 macrophage polarization and suppresses intrahepatic cholangiocarcinoma progression via the CCL18/STAT3 pathway

Cancer Sci. 2024 Mar;115(3):777-790. doi: 10.1111/cas.16068. Epub 2024 Jan 16.

Abstract

Intrahepatic cholangiocarcinoma (ICC) is a highly malignant and aggressive cancer whose incidence and mortality continue to increase, whereas its prognosis remains dismal. Tumor-associated macrophages (TAMs) promote malignant progression and immune microenvironment remodeling through direct contact and secreted mediators. Targeting TAMs has emerged as a promising strategy for ICC treatment. Here, we revealed the potential regulatory function of immune responsive gene 1 (IRG1) in macrophage polarization. We found that IRG1 expression remained at a low level in M2 macrophages. IRG1 overexpression can restrain macrophages from polarizing to the M2 type, which results in inhibition of the proliferation, invasion, and migration of ICC, whereas IRG1 knockdown exerts the opposite effects. Mechanistically, IRG1 inhibited the tumor-promoting chemokine CCL18 and thus suppressed ICC progression by regulating STAT3 phosphorylation. The intervention of IRG1 expression in TAMs may serve as a potential therapeutic target for delaying ICC progression.

Keywords: CCL18; IRG1; intrahepatic cholangiocarcinoma; macrophages; polarization.

MeSH terms

  • Bile Duct Neoplasms* / pathology
  • Bile Ducts, Intrahepatic / metabolism
  • Cell Line, Tumor
  • Chemokines, CC / metabolism
  • Cholangiocarcinoma* / pathology
  • Humans
  • Macrophages / metabolism
  • Prognosis
  • STAT3 Transcription Factor / metabolism
  • Tumor Microenvironment

Substances

  • CCL18 protein, human
  • Chemokines, CC
  • STAT3 protein, human
  • STAT3 Transcription Factor